KLK3 and pachyonychia congenita: Previously, we have demonstrated that resistance mechanisms in CTCs can be characterized by mRNA-based in situ padlock probe (PLP) hybridization, using an assay that provided broad expression data of AR, AR-V7, and PSA in CTCs of PC patients [38].